期刊文献+
共找到13篇文章
< 1 >
每页显示 20 50 100
采用128层螺旋CT对2型糖尿病患者胰腺定量的研究 被引量:3
1
作者 李军宅 朱青峰 +5 位作者 李彩英 郭福倩 胡娜 张佳莉 尹兰英 杨伟力 《河北医药》 CAS 2015年第17期2601-2603,共3页
目的采用128层螺旋CT定量测量2型糖尿病患者胰腺径线、体积、胰体比及密度,探讨其临床价值。方法回顾性分析40例糖尿病患者及134例正常对照者CT胰腺影像数据,并收集临床资料,采用128层螺旋CT后处理软件测量胰腺各径线、体积及密度,观察... 目的采用128层螺旋CT定量测量2型糖尿病患者胰腺径线、体积、胰体比及密度,探讨其临床价值。方法回顾性分析40例糖尿病患者及134例正常对照者CT胰腺影像数据,并收集临床资料,采用128层螺旋CT后处理软件测量胰腺各径线、体积及密度,观察2组间差异。结果糖尿病患者较正常人胰腺头、体、尾前后径、体积、胰体比及密度明显减低(P<0.05);但胰腺长度变化不明显。男性糖尿病组头及体前后径及密度与正常组未见显著差别(P>0.05);老年组糖尿病组与正常组比较胰腺头体尾密度均未见明显减低,而中年糖尿病组尾部CT值较正常组无明显减低(P>0.05)。结论多层螺旋CT可以客观、准确定量测量胰腺,后者对糖尿病诊断及预后评估发挥重要的作用。 展开更多
关键词 2型糖尿病 体层摄影术 螺旋计算机 胰腺
下载PDF
2020年CHINET中国细菌耐药监测 被引量:345
2
作者 胡付品 郭燕 +88 位作者 朱德妹 汪复 蒋晓飞 徐英春 张小江 张朝霞 季萍 谢轶 康梅 王传清 王爱敏 徐元宏 黄颖 孙自镛 陈中举 倪语星 孙景勇 褚云卓 田素飞 胡志东 李金 俞云松 林洁 单斌 杜艳 郭素芳 魏莲花 邹凤梅 张泓 王春 胡云建 艾效曼 卓超 苏丹虹 郭大文 赵金英 喻华 黄湘宁 刘文恩 李艳明 金炎 邵春红 徐雪松 鄢超 王山梅 楚亚菲 张利侠 马娟 周树平 周艳 朱镭 孟晋华 董芳 郑红艳 胡芳芳 沈瀚 周万青 贾伟 李刚 吴劲松 卢月梅 李继红 段金菊 康建邦 马晓波 郑燕萍 郭如意 朱焱 陈运生 孟青 王世富 胡雪飞 沈继录 汪瑞忠 房华 俞碧霞 赵勇 龚萍 温开镇 张贻荣 刘江山 廖龙凤 顾洪芹 姜琳 贺雯 薛顺虹 冯佼 窦睿 岳春雷 《中国感染与化疗杂志》 CAS CSCD 北大核心 2021年第4期377-387,共11页
目的监测国内主要地区医疗机构临床分离菌对抗菌药物的敏感性。方法对全国52所医院临床分离菌采用纸片扩散法或自动化仪器法按CHINET统一监测方案进行抗菌药物敏感性试验。按2020年CLSI折点标准判断结果。结果收集2020年1—12月上述医... 目的监测国内主要地区医疗机构临床分离菌对抗菌药物的敏感性。方法对全国52所医院临床分离菌采用纸片扩散法或自动化仪器法按CHINET统一监测方案进行抗菌药物敏感性试验。按2020年CLSI折点标准判断结果。结果收集2020年1—12月上述医院临床分离菌共251 135株,其中革兰阳性菌占28.1%,革兰阴性菌占71.9%。金黄色葡萄球菌、表皮葡萄球菌和其他凝固酶阴性葡萄球菌(除假中间葡萄球菌和施氏葡萄球菌外)中甲氧西林耐药株(MRSA、MRSE和其他MRCNS)的检出率分别为31.0%、81.7%和77.5%,甲氧西林耐药株对绝大多数抗菌药物的耐药率均显著高于甲氧西林敏感株(MSSA、MSSE和其他MSCNS)。MRSA中有93.6%菌株对甲氧苄啶-磺胺甲噁唑敏感;MRSE中有89.9%的菌株对利福平敏感;未发现万古霉素耐药株。肠球菌属中粪肠球菌对多数测试抗菌药物的耐药率均显著低于屎肠球菌,两者中均有少数万古霉素耐药株。2020年儿童和成人中分离的非脑膜炎肺炎链球菌中青霉素敏感株(PSSP)(96.7%和95.5%)所占比例较2019年有所上升,青霉素中介和耐药株(PISP和PRSP)的检出率有所下降。除克雷伯菌属对亚胺培南和美罗培南的耐药率分别为21.5%和22.4%外,肠杆菌目细菌对碳青霉烯类抗生素仍高度敏感,多数菌属的耐药率低于12%。2005—2020年16年的监测显示,肺炎克雷伯菌对亚胺培南和美罗培南的耐药率从2005年的3.0%和2.9%持续上升至2018年的25.0%和26.3%,但从2019年和2020年开始呈连续下降趋势。此外,不动杆菌属对亚胺培南和美罗培南的耐药率分别为68.1%和69.0%,铜绿假单胞菌对上述两药的耐药率分别为23.2%和19.3%。结论临床分离菌对常见抗菌药物的耐药率虽仍呈增长趋势,但如碳青霉烯类耐药的肺炎克雷伯菌和铜绿假单胞菌等多种重要的碳青霉烯类耐药细菌的检出率在多年升高的情况下,近年来呈现连续下降趋势,提示加强细菌耐药监测,结合医院感染预防控制措施,对控制耐药细菌的流行播散是行之有效的。 展开更多
关键词 细菌耐药监测 药物敏感性试验 碳青霉烯类耐药革兰阴性杆菌 甲氧西林耐药金黄色葡萄球菌
下载PDF
《请您诊断》病例155答案:小脑幕孤立性纤维瘤
3
作者 王天达 席海蛟 +2 位作者 袁涛 娄蕾 全冠民 《放射学实践》 CSCD 北大核心 2022年第3期410-412,共3页
病例资料患者,男,66岁。3个月前无明显诱因出现走路不稳,反应迟钝,小便失禁,无恶心呕吐,无发热抽搐。患者自发病以来精神较差,饮食及睡眠不良,体重稍减轻。专科体检:四肢肌力及肌张力正常,膝腱反射正常,双侧巴氏征阴性,克氏征阴性。常... 病例资料患者,男,66岁。3个月前无明显诱因出现走路不稳,反应迟钝,小便失禁,无恶心呕吐,无发热抽搐。患者自发病以来精神较差,饮食及睡眠不良,体重稍减轻。专科体检:四肢肌力及肌张力正常,膝腱反射正常,双侧巴氏征阴性,克氏征阴性。常规实验室检查及胸片无异常。MRI平扫及增强:后颅窝中线偏右侧见一实性为主的较大混杂信号肿物,大小4.6cm×5.9cm×4.8cm,与小脑幕-大脑镰后部相连,挤压小脑、脑干及第四脑室,第四脑室受压变窄,幕上脑室扩大。 展开更多
关键词 颅内肿瘤 脑膜肿瘤 孤立性纤维瘤 磁共振成像
下载PDF
阿贝西利联合氟维司群二线治疗激素受体阳性的晚期乳腺癌的药物经济学评价 被引量:4
4
作者 贾才凤 冯章英 +4 位作者 张森 徐浩 康朔 李赛男 王明霞 《中国现代应用药学》 CAS CSCD 北大核心 2023年第12期1609-1614,共6页
目的 从中国卫生体系角度评价阿贝西利联合氟维司群对比单用氟维司群二线治疗激素受体(hormone receptor,HR)阳性的晚期乳腺癌的经济性。方法 利用MONARCH 2临床试验公布的生存数据及相关成本和效用数据构建分区生存模型,模型循环周期设... 目的 从中国卫生体系角度评价阿贝西利联合氟维司群对比单用氟维司群二线治疗激素受体(hormone receptor,HR)阳性的晚期乳腺癌的经济性。方法 利用MONARCH 2临床试验公布的生存数据及相关成本和效用数据构建分区生存模型,模型循环周期设为4周,模拟时限为20年,贴现率设为5%。模型的产出指标为成本和质量调整生命年(quality-adjusted lifeyear, QALY),模型评价指标为增量成本-效果比(incrementalcost-effectivenessratio, ICER)。意愿支付阈值(willingness-to-pay threshold,WTP)为2021年中国1~3倍人均GDP(80 976元/QALY~242 928元/QALY)。进行不确定性分析以评价模型结果的稳健性。结果 基础分析结果显示,阿贝西利联合氟维司群同单用氟维司群相比可带来更多的健康获益,但同时总成本更高。增量效用及增量成本分别0.88 QALYs和306 014.57元,两方案相比的ICER值为348 507.45元/QALY。不确定性分析证实了模型结果具有稳健性。当阿贝西利价格降低70%时,阿贝西利联合氟维司群在中国3倍人均GDP下具有经济性的概率>50%。结论 阿贝西利联合氟维司群同单用氟维司群相比在二线治疗HR阳性的晚期乳腺癌患者时不具有成本-效果优势,但在北京、上海等较发达地区,阿贝西利联合氟维司群具有经济学优势。 展开更多
关键词 阿贝西利 氟维司群 晚期乳腺癌 HR阳性 药物经济学
原文传递
优替德隆联合卡培他滨二线治疗转移性乳腺癌的药物经济学评价 被引量:1
5
作者 张森 贾才凤 +2 位作者 徐浩 李赛男 康朔 《中国现代应用药学》 CAS CSCD 北大核心 2023年第19期2732-2737,共6页
目的从中国卫生体系角度评价优替德隆联合卡培他滨与单用卡培他滨相比二线治疗转移性乳腺癌的经济性。方法利用临床试验数据和相关文献数据建立分区生存模型,模型的循环周期设为3周,模拟时限为15年,成本和效用数据均采用5%的贴现率进行... 目的从中国卫生体系角度评价优替德隆联合卡培他滨与单用卡培他滨相比二线治疗转移性乳腺癌的经济性。方法利用临床试验数据和相关文献数据建立分区生存模型,模型的循环周期设为3周,模拟时限为15年,成本和效用数据均采用5%的贴现率进行贴现处理,模型产出指标为增量成本-效果比(incremental cost-effectiveness ratio,ICER),意愿支付阈值(willingness-to-pay,WTP)设为2021年中国1~3倍人均国内生产总值(gross domestic product,GDP)(80976元/QALY~242928元/QALY)。进行单因素敏感性分析和概率敏感性分析以评价模型参数变化时模型结果的稳定性。结果基础分析结果显示,优替德隆联合卡培他滨属于高成本高健康获益方案,2个方案相比的ICER值为393949.83元/QALY。单因素敏感性分析表明优替德隆的价格是对ICER值影响最大的因素,概率敏感性分析表明模型结果具有稳健性。结论优替德隆联合卡培他滨与单用卡培他滨相比二线治疗转移性乳腺癌不具有经济学优势,但在人均GDP超过131316元的地区,优替德隆联合卡培他滨成为具有成本-效果优势的方案。 展开更多
关键词 优替德隆 卡培他滨 转移性乳腺癌 药物经济学
原文传递
HPLC法测定艾瑞昔布片的含量 被引量:1
6
作者 卢彦芳 李飞高 张志清 《中国药房》 CAS CSCD 2013年第45期4301-4302,共2页
目的:建立测定艾瑞昔布片含量的方法。方法:采用高效液相色谱法。色谱柱为Diamonsil C18,流动相为甲醇-水(8020),流速为1.0 ml/min,检测波长为220 nm,柱温为25℃,进样量为20μl。结果:艾瑞昔布检测质量浓度线性范围为6.544~209.4μg/m(l... 目的:建立测定艾瑞昔布片含量的方法。方法:采用高效液相色谱法。色谱柱为Diamonsil C18,流动相为甲醇-水(8020),流速为1.0 ml/min,检测波长为220 nm,柱温为25℃,进样量为20μl。结果:艾瑞昔布检测质量浓度线性范围为6.544~209.4μg/m(lr=0.999 9),低、中、高质量浓度样品的平均回收率分别为100.6%、98.9%、99.4%(RSD=0.9%,n=9)。结论:建立的方法专属性好,结果准确可靠,可用于艾瑞昔布片的质量控制。 展开更多
关键词 艾瑞昔布片 高效液相色谱法 含量测定 质量控制
原文传递
肺动静脉瘘(AVF)3例报告
7
作者 郭平珍 《中外医用放射技术》 1998年第10期55-56,共2页
关键词 肺动静脉瘘 X线 CT NMR 成像
原文传递
Network pharmacology-based strategy to investigate harmacological mechanisms of Isodon serra(Maxim.)Hara for treatment of inflammatory 被引量:2
8
作者 Weiwei Xie Xuqing Wen +4 位作者 Dedong Zhang Yuqian Zhang Zhiqing Zhang Yiran Jin Yingfeng Du 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第4期250-263,共14页
Widely distributed in plants,ent-kaurane diterpenoids could reduce the incidence of inflammatory.The most important active ingredient of Isodon serra(Maxim.)Hara is ent-kaurane diterpenoids,which contribute to the ant... Widely distributed in plants,ent-kaurane diterpenoids could reduce the incidence of inflammatory.The most important active ingredient of Isodon serra(Maxim.)Hara is ent-kaurane diterpenoids,which contribute to the anti-inflammatory pharmacological effects of Isodon serra.However,the ingredients,the active compounds,drug targets,inflammatory targets and exact molecular mechanism of Isodon serra in treating inflammatory are still unclear.The purpose of this study was to use the method of network pharmacological analysis to find the active compounds in Isodon serra.These active compounds match the library of ent-kaurane diterpenoids compounds we established,and we find all the eligible ent-kaurane diterpenoids compounds.Isodon serra related and anti-inflammatory targets were found and then combined to get intersection,which represented potential anti-inflammatory targets of active compounds in Isodon serra.Moreover,anti-inflammatory targets and active compounds targets protein-protein interaction network were merged to get the protein-protein interaction network intersection and core genes in anti-inflammatory target protein-protein interaction network.For the anti-inflammatory targets of Isodon serra,Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis were executed to confirm gene functions of Isodon serra in antagonizing inflammation.Finally,TCMSP analysis identified 10 active compounds out of 48 ent-kaurane.The pathway analysis showed enrichment for different pathways like AGE-RAGE signaling pathway in diabetic complications,small cell lung cancer and human cytomegalovirus infection,which were all connected to inflammatory.On the whole,the proposed method clearly identified the ent-kaurane diterpenoids of Isodon serra and the results gave the active compounds of Isodon serra for the first time.The combining use of the qualitative analysis of traditional Chinese medicine(TCM)and network pharmacological methods could discover potential drug targets and reveal the biological process of TCM,which would open up a new approach in the study of TCM in future. 展开更多
关键词 Isodon serra(Maxim.)Hara Network pharmacology Active compounds ent-Kaurane diterpenoids Inflammatory targets
原文传递
Evaluation of ceftriaxone dosing regimens based on PK/PD models and Monte Carlo simulations 被引量:1
9
作者 Ye Yuan Yanan Li +2 位作者 Qing Zhao Bo Yu Xiuling Yang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第5期382-388,共7页
In the present study,we optimized the ceftriaxone dosing regimens based on pharmacokinetic/pharmacodynamic(PK/PD)principles using Monte Carlo simulation(MCS).Based on PK/PD theory,MCS was performed using Crystal Ball ... In the present study,we optimized the ceftriaxone dosing regimens based on pharmacokinetic/pharmacodynamic(PK/PD)principles using Monte Carlo simulation(MCS).Based on PK/PD theory,MCS was performed using Crystal Ball software combining PK and PD parameters with 10000 simulation runs to calculate the probability of target attainment(PTA)and cumulative fraction of response(CFR)for the seven clinically common dosing regimens of ceftriaxone(1 g qd,1.5 g qd,1 g bid,2 g qd,1 g tid,1.5 g bid,and 2 g bid).A%fT≥50 as the target value expected to achieve satisfactory clinical efficacy and a dosing regimen with an obtained CFR≥90%or the ability to achieve the highest PTA was used as a reasonable choice for empirical antimicrobial therapy,i.e.the clinically optimal regimen.All eight pathogenic bacteria had a CFR>90%when the dosing regimen was 2 g bid and 1 g tid,seven pathogenic bacteria had a CFR>90%when the dosing regimen was 1 g bid and 1.5 g bid,except for Pseudomonas aeruginosa,and all pathogenic bacteria had a CFR<90%when the dosing regimen was 1 g qd and 1.5 g qd.The dosing regimens of 2 g bid and 1 g tid were effective against all eight pathogenic bacteria infections,and 1 g bid and 1.5 g bid dosing regimens were effective against the other seven pathogenic bacteria except for Pseudomonas aeruginosa. 展开更多
关键词 CEFTRIAXONE PK/PD Monte Carlo simulation Antibacterial drugs Clinical efficacy
原文传递
胶原酶溶解术治疗腰椎间盘突出的术后护理和出院指导
10
作者 张新荣 张念玲 《中外医用放射技术》 2001年第6期18-18,共1页
关键词 腰椎间盘突出 胶原酶溶解术 治疗 术后 护理 出院指导
原文传递
Pharmacological monitoring and literature analysis of dagliflozin in patients with hypovolemia
11
作者 Ye Yuan Bo Yu +2 位作者 Zhenzhen Yang Weichong Dong Xiuling Yang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第9期718-722,共5页
In the present study,we aimed to explore the timing of dosing with dapagliflozin(DAPA)in patients with hypovolemia and the role of the clinical pharmacist in pharmacological monitoring.The clinical pharmacist was invo... In the present study,we aimed to explore the timing of dosing with dapagliflozin(DAPA)in patients with hypovolemia and the role of the clinical pharmacist in pharmacological monitoring.The clinical pharmacist was involved in the dosing regimen of two patients with hypovolemia using DAPA and advising patients with insufficient blood volume to withhold the use of the drug.They reviewed the relevant literature to provide a theoretical basis for clinicians and the role of clinical pharmacists in pharmacy services.When considering patients with hypovolemia,the clinical pharmacist can promptly identify that DAPA can reduce blood volume and provide rational advice and rationale for the patient‟s medication that is adopted by the clinician,resulting in an individualized dosing regimen for the patient.Clinical pharmacists are advised to pay attention to the dosing adjustments of DAPA when patients are in hypovolemia and to be more alert to the adverse effects that can result from its use. 展开更多
关键词 Dagliflozin HYPOVOLEMIA Pharmacological monitoring Literature analysis Clinical pharmacist
原文传递
Effects of Zhenyuan capsule on the pharmacokinetics comparison of simvastatin and its active metabolites in rats
12
作者 Ye Yuan Bo Yu +2 位作者 Xueqin Zhang Yanan Li Shumei Wang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2020年第7期494-503,共10页
The total ginsenosides of ginseng fruit are the main constituents of Zhenyuan capsule,which is mainly used for the treatment of cardiovascular diseases.It has been reported that ginsenoside can affect the activity of ... The total ginsenosides of ginseng fruit are the main constituents of Zhenyuan capsule,which is mainly used for the treatment of cardiovascular diseases.It has been reported that ginsenoside can affect the activity of CYP450 enzymes.Zhenyuan capsule and simvastatin may interact with each other through CYP3 A4 mediation,then affect the efficacy and even produce adverse reactions.However,no studies have investigated the effects of Zhenyuan capsule on the pharmacokinetics of simvastatin and its active metabolites.In this study,liquid chromatography–electrospray ionization–mass spectrometry(LC-MS/MS)was used to detect the pharmacokinetics of simvastatin and its active metabolites-simvastatin acid with or without Zhenyuan capsule in rats.Compared with the simvastatin alone,the pharmacokinetic parameters of simvastatin and simvastatin acid were significantly different in AUC0–24 and AUC0–∞,and they were decreased in varying degrees(P<0.05).It appeared that the Zhenyuan capsule might increase the activity of CYP3 A4 to some extent. 展开更多
关键词 Zhenyuan capsule SIMVASTATIN Simvastatin acid LC-MS/MS PHARMACOKINETICS
原文传递
Determination of free ceftriaxone concentration and its application in predicting lung tissue concentration
13
作者 Yanan Li Xue Guo +2 位作者 Ye Yuan Weichong Dong Xiuling Yang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第7期578-589,共12页
The purpose of this study was to establish a method for determining the free concentration of ceftriaxone based on hollow fiber centrifugal ultrafiltration(HFCF-UF)technology in combination with high-performance liqui... The purpose of this study was to establish a method for determining the free concentration of ceftriaxone based on hollow fiber centrifugal ultrafiltration(HFCF-UF)technology in combination with high-performance liquid chromatography(HPLC)for free pharmacokinetic studies and the prediction of ceftriaxone concentrations in lung tissue.This method only required centrifugation for a short time,and the filtrate could be injected directly for HPLC analysis without further treatment.The specificity,linearity,precision and stability of this method were validated for quantification of free ceftriaxone.Under the optimized conditions,the absolute recoveries were more than 92.5%.The intraday and interday precision RSDs were less than 3.6%.Additionally,nonspecific adsorption(NSB)between the analyte and the ultrafiltration membrane was considered.This method was successfully applied to the analysis of the free ceftriaxone concentration in rat plasma and lung tissue.The free ceftriaxone concentration of lung tissue could be predicted by using the linear formula Cfl=Cfp(0.342 x–0.0129)(x:time).This method also provides a reliable alternative for accurate monitoring of the free ceftriaxone concentration in therapeutic drug monitoring(TDM). 展开更多
关键词 CEFTRIAXONE Free tissue concentration Hollow fiber centrifugal ultrafiltration PHARMACOKINETICS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部